These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17020433)

  • 21. Is gene array testing to be considered routine now?
    Paik S
    Breast; 2011 Oct; 20 Suppl 3():S87-91. PubMed ID: 22015300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical review of microarray-based prognostic tests and trials in breast cancer.
    Koscielny S
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):47-50. PubMed ID: 18197005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular classification and molecular forecasting of breast cancer: ready for clinical application?
    Brenton JD; Carey LA; Ahmed AA; Caldas C
    J Clin Oncol; 2005 Oct; 23(29):7350-60. PubMed ID: 16145060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When will tumor gene expression profiling be incorporated into clinical breast cancer decision making?
    Creighton CJ; Rae JM
    Breast Cancer Res; 2006; 8(4):302. PubMed ID: 16834787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Radiobiology and breast cancer molecular classification: present or future?].
    Bourgier C; Heymann S; Vielh P; Azria D
    Cancer Radiother; 2012 Feb; 16(1):29-33. PubMed ID: 22266303
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The value of gene expression profiles using micoarrays for the individualisation of adjuvant therapy after surgery for breast cancer].
    Klijn JG; de Vries EG
    Ned Tijdschr Geneeskd; 2005 Mar; 149(12):618-22. PubMed ID: 15813427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognostic classification of breast cancer and gene expression profiling].
    Bertucci F; Finetti P; Cervera N; Birnbaum D
    Med Sci (Paris); 2008; 24(6-7):599-606. PubMed ID: 18601877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer.
    Acharya CR; Hsu DS; Anders CK; Anguiano A; Salter KH; Walters KS; Redman RC; Tuchman SA; Moylan CA; Mukherjee S; Barry WT; Dressman HK; Ginsburg GS; Marcom KP; Garman KS; Lyman GH; Nevins JR; Potti A
    JAMA; 2008 Apr; 299(13):1574-87. PubMed ID: 18387932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.
    Jézéquel P; Campone M; Roché H; Gouraud W; Charbonnel C; Ricolleau G; Magrangeas F; Minvielle S; Genève J; Martin AL; Bataille R; Campion L
    Breast Cancer Res Treat; 2009 Aug; 116(3):509-20. PubMed ID: 19020972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?
    Sotiriou C; Piccart MJ
    Nat Rev Cancer; 2007 Jul; 7(7):545-53. PubMed ID: 17585334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of DNA microarray technology in determining breast cancer prognosis and therapeutic response.
    Brennan DJ; O'Brien SL; Fagan A; Culhane AC; Higgins DG; Duffy MJ; Gallagher WM
    Expert Opin Biol Ther; 2005 Aug; 5(8):1069-83. PubMed ID: 16050784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer Grade Model: a multi-gene machine learning-based risk classification for improving prognosis in breast cancer.
    Amiri Souri E; Chenoweth A; Cheung A; Karagiannis SN; Tsoka S
    Br J Cancer; 2021 Aug; 125(5):748-758. PubMed ID: 34131308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gene expression profiling using cDNA arrays and prognosis of breast cancer].
    Bertucci F; Nasser V; Houlgatte R; Birnbaum D
    Bull Cancer; 2002 Jun; 89(6):571-4. PubMed ID: 12135856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Genome-wide expression profiling as a clinical tool: are we there yet?].
    Geyer FC; Decker T; Reis-Filho JS
    Pathologe; 2009 Mar; 30(2):141-6. PubMed ID: 19219435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent translational research: microarray expression profiling of breast cancer--beyond classification and prognostic markers?
    Wilson CA; Dering J
    Breast Cancer Res; 2004; 6(5):192-200. PubMed ID: 15318924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [DNA microarrays for gene expression profiling of breast cancer: principles and prognostic applications].
    Bertucci F; Viens P; Birnbaum D
    Pathol Biol (Paris); 2006 Feb; 54(1):49-54. PubMed ID: 16376179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular classification of breast carcinomas with particular emphasis on "basal-like" carcinoma: a critical review.
    Lavasani MA; Moinfar F
    J Biophotonics; 2012 Apr; 5(4):345-66. PubMed ID: 22232077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mixture classification model based on clinical markers for breast cancer prognosis.
    Zeng T; Liu J
    Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving the prediction of chemotherapeutic sensitivity of tumors in breast cancer via optimizing the selection of candidate genes.
    Jiang L; Huang L; Kuang Q; Zhang J; Li M; Wen Z; He L
    Comput Biol Chem; 2014 Apr; 49():71-8. PubMed ID: 24440656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer diagnosis and microarrays.
    Schmidt U; Begley CG
    Int J Biochem Cell Biol; 2003 Feb; 35(2):119-24. PubMed ID: 12479861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.